idursulfase 6 MG in 3 ML Injection
- RxCUI
- 644104
- RxNorm name
- idursulfase 6 MG in 3 ML Injection
- Display name
- idursulfase 6 MG in 3 ML Injection
- Full name
- idursulfase 6 MG in 3 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125151 | Elaprase | idursulfase | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ELAPRASE | IDURSULFASE | Takeda Pharmaceuticals America, Inc. | 60cba843-5aab-4dd7-96dc-66648d413be3 | 2025-04-15 | Boxed warning, Warnings, Adverse reactions | 644104 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 60cba843-5aab-4dd7-96dc-66648d413be3 | idursulfase 6 MG in 3 ML Injection [PSN] · 3 ML idursulfase 2 MG/ML Injection [SCD] · idursulfase 6 MG per 3 ML Injection [SY] | 3 | 25 | These highlights do not include all the information needed to use ELAPRASE safely and effectively. See full prescribing information for ELAPRASE. ELAPRASE ® (idursulfase) injection, for intravenous use Initial U.S. Approval: 2006 | 20250415 |